Kenya approves long-acting HIV prevention injection Lenacapavir
|
Kenya has approved Lenacapavir, a twice-yearly HIV
prevention injection, after a rigorous regulatory review by the Pharmacy and
Poisons Board. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.